People with allergic fungal rhinosinusitis taking Dupixent saw significant improvement in congestion and sinus inflammation, ...
Spring is still more than three weeks away, but experts say now is the time to get ready for seasonal allergies.
The FDA approved dupilumab (Dupixent) for treating allergic fungal rhinosinusitis, a first for the condition, the agency announced on Wednesday. Approval stipulates use in individuals 6 years and ...
One potential new treatment could be a game-changer when it comes to universal protection against a variety of illnesses, including COVID-19, influenza, and spring pollen.
Many Texarkana residents are already feeling the effects of spring allergy season, from sneezing to watery eyes and ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who has violent sneezing fits after eating. FATIGUE can hit hard as the winter ...
Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...
A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue ...
A Magical Mess on MSN
8 common over-the-counter medications doctors are now cautioning against
You walk into any drugstore today, and the shelves are packed with medications you can grab without a prescription. Seems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results